SANARA MEDTECH INC (SMTI) Stock Price & Overview
NASDAQ:SMTI • US79957L1008
Current stock price
The current stock price of SMTI is 17.29 USD. Today SMTI is up by 1.95%. In the past month the price decreased by -15.58%. In the past year, price decreased by -37.78%.
SMTI Key Statistics
- Market Cap
- 154.573M
- P/E
- N/A
- Fwd P/E
- 26.08
- EPS (TTM)
- -0.51
- Dividend Yield
- N/A
SMTI Stock Performance
SMTI Stock Chart
SMTI Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SMTI. When comparing the yearly performance of all stocks, SMTI is a bad performer in the overall market: 89.76% of all stocks are doing better.
SMTI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SMTI. Both the profitability and financial health of SMTI have multiple concerns.
SMTI Earnings
On March 24, 2026 SMTI reported an EPS of 0.04 and a revenue of 27.55M. The company missed EPS expectations (-64.35% surprise) and missed revenue expectations (-1.42% surprise).
SMTI Forecast & Estimates
8 analysts have analysed SMTI and the average price target is 36.72 USD. This implies a price increase of 112.38% is expected in the next year compared to the current price of 17.29.
For the next year, analysts expect an EPS growth of 229.49% and a revenue growth 15.65% for SMTI
SMTI Groups
Sector & Classification
SMTI Financial Highlights
Over the last trailing twelve months SMTI reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 55.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.5% | ||
| ROE | -632.54% | ||
| Debt/Equity | 7.74 |
SMTI Ownership
SMTI Latest News, Press Relases and Analysis
SMTI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 28.56 | 55.99B | ||
| COO | COOPER COS INC/THE | 13.86 | 13.523B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.45 | 11.851B | ||
| SOLV | SOLVENTUM CORP | 9.66 | 11.008B | ||
| LNTH | LANTHEUS HOLDINGS INC | 13.54 | 4.722B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.57 | 4.079B | ||
| ICUI | ICU MEDICAL INC | 15.15 | 3.096B | ||
| HAE | HAEMONETICS CORP/MASS | 10.22 | 2.553B | ||
| XRAY | DENTSPLY SIRONA INC | 7.64 | 2.237B | ||
| NEOG | NEOGEN CORP | 26.27 | 1.938B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.32 | 1.44B | ||
| STAA | STAAR SURGICAL CO | 129.76 | 908.013M | ||
| BVS | BIOVENTUS INC - A | 11.47 | 745.024M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SMTI
Company Profile
Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. The company markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Company Info
IPO: 1994-04-07
SANARA MEDTECH INC
1200 Summit Avenue, Suite 414
Fort Worth TEXAS 76102 US
CEO: Ronald T. Nixon
Employees: 141
Phone: 18175292300
SANARA MEDTECH INC / SMTI FAQ
What does SMTI do?
Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. The company markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Can you provide the latest stock price for SANARA MEDTECH INC?
The current stock price of SMTI is 17.29 USD. The price increased by 1.95% in the last trading session.
Does SMTI stock pay dividends?
SMTI does not pay a dividend.
How is the ChartMill rating for SANARA MEDTECH INC?
SMTI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What sector and industry does SANARA MEDTECH INC belong to?
SANARA MEDTECH INC (SMTI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is SANARA MEDTECH INC worth?
SANARA MEDTECH INC (SMTI) has a market capitalization of 154.57M USD. This makes SMTI a Micro Cap stock.